FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway

Background: Cardiac hypertrophy was accompanied by various cardiovascular diseases (CVDs), and due to the high global incidence and mortality of CVDs, it has become increasingly critical to characterize the pathogenesis of cardiac hypertrophy. We aimed to determine the metabolic roles of fatty acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Lingfang, Mao, Ye, Liu, Zizhu, Li, Chenni, Jin, Qi, Lu, Lin, Tao, Rong, Yan, Xiaoxiang, Chen, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387950/
https://www.ncbi.nlm.nih.gov/pubmed/34458345
http://dx.doi.org/10.3389/fcvm.2021.722908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387950/
https://www.ncbi.nlm.nih.gov/pubmed/34458345
http://dx.doi.org/10.3389/fcvm.2021.722908

Ejemplares similares